{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:01:18Z","timestamp":1770220878423,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":2478,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jpainsymman.2012.03.001","type":"journal-article","created":{"date-parts":[[2012,7,21]],"date-time":"2012-07-21T07:45:25Z","timestamp":1342856725000},"page":"776-781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Use of Pregabalin in the Management of\u00a0Chronic Uremic Pruritus"],"prefix":"10.1016","volume":"45","author":[{"given":"Linda","family":"Shavit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tal","family":"Grenader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meyer","family":"Lifschitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itzchak","family":"Slotki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2012.03.001_bib1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1055\/s-2008-1043102","volume":"121","author":"Mettang","year":"1996","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.jpainsymman.2012.03.001_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ejpain.2006.03.005","article-title":"Chronic itch and pain\u2014similarities and differences","volume":"10","author":"Stander","year":"2006","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpainsymman.2012.03.001_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0304-3940(89)90460-6","article-title":"Intraepidermal neuron-specific enolase (NSE)-immunoreactive nerve fibres: evidence for sprouting in uremic patients on maintenance hemodialysis","volume":"99","author":"Johansson","year":"1989","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpainsymman.2012.03.001_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3959(03)00173-8","article-title":"Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C","volume":"105","author":"Fehrenbacher","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2012.03.001_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJM196809262791308","article-title":"Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy","volume":"279","author":"Massry","year":"1968","journal-title":"N\u00a0Engl J\u00a0Med"},{"key":"10.1016\/j.jpainsymman.2012.03.001_bib6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2796.1989.tb00104.x","article-title":"Experimental and immunohistochemical studies on the possible role of parathyroid hormone in uraemic pruritus","volume":"225","author":"Stahle-Backdahl","year":"1989","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jpainsymman.2012.03.001_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0272-6386(85)80115-3","article-title":"Uremic pruritus: skin divalent ion content and response to ultraviolet phototherapy","volume":"5","author":"Blachley","year":"1985","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jpainsymman.2012.03.001_bib8","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/oxfordjournals.ndt.a027092","article-title":"Pruritus and skin hydration during dialysis","volume":"11","author":"Morton","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jpainsymman.2012.03.001_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0987-7053(01)00257-X","article-title":"Is pruritus in chronic uremic patients related to peripheral somatic and autonomic neuropathy? Study by R-R interval variation test (RRIV) and by sympathetic skin response (SSR)","volume":"31","author":"Zakrzewska-Pniewska","year":"2001","journal-title":"Neurophysiol Clin"},{"key":"10.1016\/j.jpainsymman.2012.03.001_bib10","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(96)04176-1","article-title":"Randomised crossover trial of naltrexone in uraemic pruritus","volume":"348","author":"Peer","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jpainsymman.2012.03.001_bib11","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/ndt\/gfh131","article-title":"Regression of uraemic pruritus by cyclosporin treatment in a haemodialysis patient","volume":"19","author":"Fusaro","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jpainsymman.2012.03.001_bib12","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/ndt\/gfh496","article-title":"Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial","volume":"19","author":"Gunal","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jpainsymman.2012.03.001_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3346\/jkms.2003.18.2.255","article-title":"Spinal gabapentin and antinociception: mechanisms of action","volume":"18","author":"Yoon","year":"2003","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.jpainsymman.2012.03.001_bib14","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jaad.2007.07.017","article-title":"Pregabalin in the treatment of chronic pruritus","volume":"58","author":"Ehrchen","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jpainsymman.2012.03.001_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jpainsymman.2006.07.006","article-title":"Efficacy of pregabalin in the management of cetuximab-related itch","volume":"32","author":"Porzio","year":"2006","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2012.03.001_bib16","first-page":"180","article-title":"The use of pregabalin in the treatment of uraemic pruritus in haemodialysis patients","volume":"36","author":"Aperis","year":"2010","journal-title":"J\u00a0Ren Care"},{"key":"10.1016\/j.jpainsymman.2012.03.001_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0091270003251119","article-title":"Pharmacokinetics of pregabalin in subjects with various degrees of renal function","volume":"43","author":"Randinitis","year":"2003","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"Suppl 5","key":"10.1016\/j.jpainsymman.2012.03.001_bib18","doi-asserted-by":"crossref","first-page":"v3","DOI":"10.1093\/ndt\/gfm292","article-title":"Itchy skin\u2014a clinical problem for haemodialysis patients","volume":"22","author":"Wikstrom","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jpainsymman.2012.03.001_bib19","first-page":"157","article-title":"Skin problems in chronic kidney disease","volume":"5","author":"Kuypers","year":"2009","journal-title":"Nat Clin Pract Nephrol"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392412002382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392412002382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:09:10Z","timestamp":1760130550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392412002382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0885392412002382"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.03.001","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Pregabalin in the Management of\u00a0Chronic Uremic Pruritus","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2012.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}